Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Gynecologic 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 11Carcinoma, Intraductal, Noninfiltrating 4Carcinoma, Ductal, Breast 3Breast Carcinoma In Situ 2Stomach Neoplasms 1Skin Abnormalities 1Radiodermatitis 1Radiation Injuries 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Liver Neoplasms 1Inflammation 1Fatigue 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Lobular 1Carcinoma, Hepatocellular 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

pembrolizumab 6Drug Therapy 3Cyclophosphamide 3spartalizumab 2fludarabine 2Sirolimus 2Riluzole 2Oncolytic Virotherapy 2Ipilimumab 2Blood Specimen Collection 2vofatamab 1tocilizumab 1saracatinib 1poly ICLC 1pertuzumab 1pazopanib 1liposomal doxorubicin 1ixabepilone 1fludarabine phosphate 1enzalutamide 1durvalumab 1cediranib 1brodalumab 1atezolizumab 1aldesleukin 1advexin 1Ultrasonography 1Tissue Banks 1TKM-080301 1Ritonavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Radiotherapy, Conformal × Breast × Clear all
NCT00553683 2014-01-14

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Rutgers, The State University of New Jersey

Phase 1/2 Unknown
50 enrolled
BreastDermatologicGastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Colonic Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡